Literature DB >> 23677113

Dasatinib-induced leukotrichia in a patient with chronic myelogenous leukemia.

Sara Samimi, Emily Chu, John Seykora, Alison Loren, Carmela Vittorio, Alain Rook, Misha Rosenbach, Ellen J Kim.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23677113     DOI： 10.1001/jamadermatol.2013.75

Source DB:  PubMed          Journal:  JAMA Dermatol        ISSN： 2168-6068            Impact factor:   10.282


× No keyword cloud information.
  3 in total

Review 1.  Pigmentary changes in patients treated with targeted anticancer agents: A systematic review and meta-analysis.

Authors:  Julia Dai; Viswanath R Belum; Shenhong Wu; Vincent Sibaud; Mario E Lacouture
Journal:  J Am Acad Dermatol       Date:  2017-09-14       Impact factor: 11.527

2.  Development of Asymmetric Facial Depigmentation in a Patient Treated with Dasatinib with New-Onset Hypovitaminosis D: Case Report and Review of the Literature.

Authors:  Kirsten C Webb; Magdalena Harasimowicz; Monica Janeczek; Jodi Speiser; James Swan; Rebecca Tung
Journal:  Case Rep Dermatol Med       Date:  2017-03-23

3.  Dasatinib-Induced Hypopigmentation in Pediatric Patient with Chronic Myeloid Leukemia: A Case Report and Review of the Literature.

Authors:  Bader Alharbi; Samer Alamri; Ahmed Mahdi; Siham Marghalani
Journal:  Case Rep Dermatol Med       Date:  2018-07-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.